|  |  | Predicted sensitivity to EGFR TKI | |||
---|---|---|---|---|---|---|
 | Cell Line | Experimental Sensitivity to EGFR TKI (erlotinib) | Prediction based on analysis of mutational status alone (Exons 18–21) | Genomic signature/DLDA |  |  |
 |  |  |  | 10-genes | 50-genes | 180-genes |
Training | A549 | No | √ | √* | √ | √ |
 | UKY-29 | No | √ |  | √ | √ |
 | H1650 | Yes | √ | √ | √ | √ |
 | PC-9 | Yes | √ | √ | √ | √ |
 | H3255 | Yes | √ | √ | √ | √ |
Validation | H358 | Yes |  | √ | √ | √ |
 | H460 | No | √ | √ | √ | √ |
 | H1975 | No | √ |  |  |  |
 | K562 | No | √ | √ | √ | √ |
 | A431 | Yes |  | √ | √ | √ |
 |  | % Correct | 80% | 80% | 90% | 90% |